188 related articles for article (PubMed ID: 8943676)
1. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
[TBL] [Abstract][Full Text] [Related]
2. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
3. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.
Hoefnagel CA
Eur J Nucl Med; 1994 Jun; 21(6):561-81. PubMed ID: 7915987
[TBL] [Abstract][Full Text] [Related]
4. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
[TBL] [Abstract][Full Text] [Related]
5. Scintiscans and carcinoid tumors.
Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C
Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096
[TBL] [Abstract][Full Text] [Related]
6. MIBG and radiolabeled octreotide in neuroendocrine tumors.
Hoefnagel CA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
[TBL] [Abstract][Full Text] [Related]
7. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
8. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
[TBL] [Abstract][Full Text] [Related]
9. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.
Fischer M; Kamanabroo D; Sonderkamp H; Proske T
Lancet; 1984 Jul; 2(8395):165. PubMed ID: 6146062
[No Abstract] [Full Text] [Related]
11. Somatostatin analogue scintigraphy in carcinoid tumours.
Kwekkeboom DJ; Krenning EP; Bakker WH; Oei HY; Kooij PP; Lamberts SW
Eur J Nucl Med; 1993 Apr; 20(4):283-92. PubMed ID: 8491220
[TBL] [Abstract][Full Text] [Related]
12. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
[TBL] [Abstract][Full Text] [Related]
14. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
[TBL] [Abstract][Full Text] [Related]
15. 131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin.
Orsolon P; Bagni B
Minerva Endocrinol; 1995 Jun; 20(2):145-7. PubMed ID: 8531897
[TBL] [Abstract][Full Text] [Related]
16. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
17. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
[TBL] [Abstract][Full Text] [Related]
18. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
[TBL] [Abstract][Full Text] [Related]
19. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.
Wiseman GA; Kvols LK
Semin Nucl Med; 1995 Jul; 25(3):272-8. PubMed ID: 7570046
[TBL] [Abstract][Full Text] [Related]
20. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]